1. Home
  2. TECH vs HSIC Comparison

TECH vs HSIC Comparison

Compare TECH & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • HSIC
  • Stock Information
  • Founded
  • TECH 1976
  • HSIC 1932
  • Country
  • TECH United States
  • HSIC United States
  • Employees
  • TECH N/A
  • HSIC N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • HSIC Medical Specialities
  • Sector
  • TECH Health Care
  • HSIC Health Care
  • Exchange
  • TECH Nasdaq
  • HSIC Nasdaq
  • Market Cap
  • TECH 7.8B
  • HSIC 9.0B
  • IPO Year
  • TECH 1989
  • HSIC 1995
  • Fundamental
  • Price
  • TECH $57.09
  • HSIC $69.60
  • Analyst Decision
  • TECH Buy
  • HSIC Buy
  • Analyst Count
  • TECH 12
  • HSIC 11
  • Target Price
  • TECH $69.82
  • HSIC $75.64
  • AVG Volume (30 Days)
  • TECH 2.2M
  • HSIC 2.0M
  • Earning Date
  • TECH 08-06-2025
  • HSIC 08-05-2025
  • Dividend Yield
  • TECH 0.56%
  • HSIC N/A
  • EPS Growth
  • TECH N/A
  • HSIC 15.03
  • EPS
  • TECH 0.46
  • HSIC 3.11
  • Revenue
  • TECH $1,219,635,000.00
  • HSIC $12,773,000,000.00
  • Revenue This Year
  • TECH $7.33
  • HSIC $4.31
  • Revenue Next Year
  • TECH $9.32
  • HSIC $3.57
  • P/E Ratio
  • TECH $124.26
  • HSIC $21.94
  • Revenue Growth
  • TECH 5.23
  • HSIC 2.29
  • 52 Week Low
  • TECH $46.01
  • HSIC $60.56
  • 52 Week High
  • TECH $80.95
  • HSIC $82.49
  • Technical
  • Relative Strength Index (RSI)
  • TECH 60.85
  • HSIC 53.03
  • Support Level
  • TECH $53.89
  • HSIC $67.78
  • Resistance Level
  • TECH $54.95
  • HSIC $68.97
  • Average True Range (ATR)
  • TECH 1.93
  • HSIC 1.68
  • MACD
  • TECH 0.25
  • HSIC 0.34
  • Stochastic Oscillator
  • TECH 96.52
  • HSIC 88.00

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: